Ibrance
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0069-0189 -
Package NDC
0069-0189-21 -
Application number
NDA207103 -
SPL ID
7dcc9b87-0aa4-4a00-aced-96be3553e8ac -
SPL set ID
e0e6412f-50b4-4fd4-9364-62818d121a07 -
UNII
G9ZF61LE7G -
RxCUI
1601380 -
RxCUI
1601386 -
RxCUI
1601388 -
RxCUI
1601390 -
RxCUI
1601392 -
RxCUI
1601394
What the source publishes
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Active ingredients
- palbociclib
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Ibrance",
"splId": "7dcc9b87-0aa4-4a00-aced-96be3553e8ac",
"labels": [
{
"setId": "e0e6412f-50b4-4fd4-9364-62818d121a07",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e0e6412f-50b4-4fd4-9364-62818d121a07",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e0e6412f-50b4-4fd4-9364-62818d121a07"
}
],
"routes": [
"ORAL"
],
"labeler": "Pfizer Laboratories Div Pfizer Inc",
"finished": true,
"packaging": [
{
"sample": false,
"description": "21 CAPSULE in 1 BOTTLE (0069-0189-21)",
"package_ndc": "0069-0189-21",
"identifierStatus": "well-formed",
"marketing_start_date": "20150203"
}
],
"productId": "0069-0189_7dcc9b87-0aa4-4a00-aced-96be3553e8ac",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "0069-0189",
"deaSchedule": null,
"genericName": "palbociclib",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "PALBOCICLIB",
"strength": "125 mg/1"
}
],
"applicationNumber": "NDA207103",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20150203",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175605",
"N0000175082",
"N0000190114"
],
"upc": [
"0300690188218",
"0300690189215",
"0300690187211"
],
"unii": [
"G9ZF61LE7G"
],
"rxcui": [
"1601380",
"1601386",
"1601388",
"1601390",
"1601392",
"1601394"
],
"spl_set_id": [
"e0e6412f-50b4-4fd4-9364-62818d121a07"
],
"pharm_class_epc": [
"Kinase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Kinase Inhibitors [MoA]",
"Cytochrome P450 3A Inhibitors [MoA]"
],
"manufacturer_name": [
"Pfizer Laboratories Div Pfizer Inc"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0069-0189_7dcc9b87-0aa4-4a00-aced-96be3553e8ac"